Cullinan Oncology, Inc. (CGEM) Tops Q4 EPS by 1c

Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q4 EPS of ($0.77), $0.01 better than the analyst estimate of ($0.78).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Honda and Nissan to jointly develop vehicle sofware, Nikkei reports
• IP Strategy Holdings receives Nasdaq noncompliance notice over late 10-Q